Cancer

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified. Read More

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read More

(photo by Joe Howell) LaManda Watson, left, receives a Team Vanderbilt T-shirt from Elizabeth Wilson for participating in the Fall Cancer Walks signup event held recently.  Vanderbilt-Ingram Cancer Center is sponsoring at least eight cancer walks this fall. For more information and to register online, visit www.viccfallwalks.org. Read More

Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone. Read More

Racial differences exist in quality surgical care, new research from VICC finds. Read More

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. Read More

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. Read More

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. Read More

Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer. Read More

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation. Read More

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More

iStock High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to a study published July 17 in the Journal of the National Cancer Institute. The study was conducted by investigators from the Shanghai Cancer Institute,… Read More

The Vanderbilt-Ingram Cancer Center debuted a new video at its annual celebration of cancer survivors recently. “This Side of Cancer” tells the story of hope and second chances from the point of three cancer survivors. The video can be viewed on YouTube. Contact:… Read More

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer. Read More

Olympic gold medal skating champion and cancer survivor Scott Hamilton was the keynote speaker at Vanderbilt-Ingram Cancer Center’s annual cancer survivors day event held at the Vanderbilt Student Life Center. Nearly 600 people attended “Going for the Gold: Living Well through Cancer,” which featured activities for cancer… Read More

An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Leora Horn, M.D. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer… Read More

Jamey Young, assistant professor of chemical and biomolecular engineering, likes to build bridges. But rather than physical structures, Young focuses on spanning the divide between biology and engineering, diabetes and cancer, and plants and animals. Read More

Study finds no evidence of increased mitochondrial mutations in the children of women treated with radiation for cancer. Read More

Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card. Read More

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read More